Global CD137 Antibody Market Growth (Status and Outlook) 2022-2028
CD137 antibody is an unconjugated antibody to CD137 (TNFRSF9 / 4-1BB).
The global market for CD137 Antibody is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CD137 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CD137 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CD137 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CD137 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CD137 Antibody players cover Sino Biological, Inc., Thermo Fisher, LifeSpan BioSciences, Inc, BioLegend and Abcam, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CD137 Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CD137 Antibody market, with both quantitative and qualitative data, to help readers understand how the CD137 Antibody market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the CD137 Antibody market and forecasts the market size by Type (Monoclonal Antibody and Polyclonal Antibody,), by Application (Flow Cytometry, ELISA, Immunoprecipitation and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibody
Polyclonal Antibody
Segmentation by application
Flow Cytometry
ELISA
Immunoprecipitation
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sino Biological, Inc.
Thermo Fisher
LifeSpan BioSciences, Inc
BioLegend
Abcam
Bio-Techne
GeneTex
Bio-Rad Laboratories, Inc.
Arigo Biolaboratories Corp.
Merck
Cell Signaling Technology, Inc.
MyBiosource, Inc.
Boster Biological Technology
Biocare Medical, LLC
Signalway Antibody LLC
NSJ Bioreagents
Leinco Technologies
Wuhan Fine Biotech Co., Ltd.
Elabscience Biotechnology Inc.
Biotium
Bioss Inc
Miltenyi Biotec
Chapter Introduction
Chapter 1: Scope of CD137 Antibody, Research Methodology, etc.
Chapter 2: Executive Summary, global CD137 Antibody market size and CAGR, CD137 Antibody market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CD137 Antibody revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CD137 Antibody revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CD137 Antibody market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., Thermo Fisher, LifeSpan BioSciences, Inc, BioLegend, Abcam, Bio-Techne, GeneTex, Bio-Rad Laboratories, Inc. and Arigo Biolaboratories Corp., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD137 Antibody Market Size 2017-2028
2.1.2 CD137 Antibody Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CD137 Antibody Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Polyclonal Antibody
2.3 CD137 Antibody Market Size by Type
2.3.1 CD137 Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CD137 Antibody Market Size Market Share by Type (2017-2022)
2.4 CD137 Antibody Segment by Application
2.4.1 Flow Cytometry
2.4.2 ELISA
2.4.3 Immunoprecipitation
2.4.4 Other
2.5 CD137 Antibody Market Size by Application
2.5.1 CD137 Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CD137 Antibody Market Size Market Share by Application (2017-2022)
3 CD137 Antibody Market Size by Player
3.1 CD137 Antibody Market Size Market Share by Players
3.1.1 Global CD137 Antibody Revenue by Players (2020-2022)
3.1.2 Global CD137 Antibody Revenue Market Share by Players (2020-2022)
3.2 Global CD137 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CD137 Antibody by Regions
4.1 CD137 Antibody Market Size by Regions (2017-2022)
4.2 Americas CD137 Antibody Market Size Growth (2017-2022)
4.3 APAC CD137 Antibody Market Size Growth (2017-2022)
4.4 Europe CD137 Antibody Market Size Growth (2017-2022)
4.5 Middle East & Africa CD137 Antibody Market Size Growth (2017-2022)
5 Americas
5.1 Americas CD137 Antibody Market Size by Country (2017-2022)
5.2 Americas CD137 Antibody Market Size by Type (2017-2022)
5.3 Americas CD137 Antibody Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD137 Antibody Market Size by Region (2017-2022)
6.2 APAC CD137 Antibody Market Size by Type (2017-2022)
6.3 APAC CD137 Antibody Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CD137 Antibody by Country (2017-2022)
7.2 Europe CD137 Antibody Market Size by Type (2017-2022)
7.3 Europe CD137 Antibody Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CD137 Antibody by Region (2017-2022)
8.2 Middle East & Africa CD137 Antibody Market Size by Type (2017-2022)
8.3 Middle East & Africa CD137 Antibody Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CD137 Antibody Market Forecast
10.1 Global CD137 Antibody Forecast by Regions (2023-2028)
10.1.1 Global CD137 Antibody Forecast by Regions (2023-2028)
10.1.2 Americas CD137 Antibody Forecast
10.1.3 APAC CD137 Antibody Forecast
10.1.4 Europe CD137 Antibody Forecast
10.1.5 Middle East & Africa CD137 Antibody Forecast
10.2 Americas CD137 Antibody Forecast by Country (2023-2028)
10.2.1 United States CD137 Antibody Market Forecast
10.2.2 Canada CD137 Antibody Market Forecast
10.2.3 Mexico CD137 Antibody Market Forecast
10.2.4 Brazil CD137 Antibody Market Forecast
10.3 APAC CD137 Antibody Forecast by Region (2023-2028)
10.3.1 China CD137 Antibody Market Forecast
10.3.2 Japan CD137 Antibody Market Forecast
10.3.3 Korea CD137 Antibody Market Forecast
10.3.4 Southeast Asia CD137 Antibody Market Forecast
10.3.5 India CD137 Antibody Market Forecast
10.3.6 Australia CD137 Antibody Market Forecast
10.4 Europe CD137 Antibody Forecast by Country (2023-2028)
10.4.1 Germany CD137 Antibody Market Forecast
10.4.2 France CD137 Antibody Market Forecast
10.4.3 UK CD137 Antibody Market Forecast
10.4.4 Italy CD137 Antibody Market Forecast
10.4.5 Russia CD137 Antibody Market Forecast
10.5 Middle East & Africa CD137 Antibody Forecast by Region (2023-2028)
10.5.1 Egypt CD137 Antibody Market Forecast
10.5.2 South Africa CD137 Antibody Market Forecast
10.5.3 Israel CD137 Antibody Market Forecast
10.5.4 Turkey CD137 Antibody Market Forecast
10.5.5 GCC Countries CD137 Antibody Market Forecast
10.6 Global CD137 Antibody Forecast by Type (2023-2028)
10.7 Global CD137 Antibody Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. CD137 Antibody Product Offered
11.1.3 Sino Biological, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sino Biological, Inc. Main Business Overview
11.1.5 Sino Biological, Inc. Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher CD137 Antibody Product Offered
11.2.3 Thermo Fisher CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 LifeSpan BioSciences, Inc
11.3.1 LifeSpan BioSciences, Inc Company Information
11.3.2 LifeSpan BioSciences, Inc CD137 Antibody Product Offered
11.3.3 LifeSpan BioSciences, Inc CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 LifeSpan BioSciences, Inc Main Business Overview
11.3.5 LifeSpan BioSciences, Inc Latest Developments
11.4 BioLegend
11.4.1 BioLegend Company Information
11.4.2 BioLegend CD137 Antibody Product Offered
11.4.3 BioLegend CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BioLegend Main Business Overview
11.4.5 BioLegend Latest Developments
11.5 Abcam
11.5.1 Abcam Company Information
11.5.2 Abcam CD137 Antibody Product Offered
11.5.3 Abcam CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Abcam Main Business Overview
11.5.5 Abcam Latest Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Information
11.6.2 Bio-Techne CD137 Antibody Product Offered
11.6.3 Bio-Techne CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Techne Main Business Overview
11.6.5 Bio-Techne Latest Developments
11.7 GeneTex
11.7.1 GeneTex Company Information
11.7.2 GeneTex CD137 Antibody Product Offered
11.7.3 GeneTex CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 GeneTex Main Business Overview
11.7.5 GeneTex Latest Developments
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Bio-Rad Laboratories, Inc. Company Information
11.8.2 Bio-Rad Laboratories, Inc. CD137 Antibody Product Offered
11.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.8.5 Bio-Rad Laboratories, Inc. Latest Developments
11.9 Arigo Biolaboratories Corp.
11.9.1 Arigo Biolaboratories Corp. Company Information
11.9.2 Arigo Biolaboratories Corp. CD137 Antibody Product Offered
11.9.3 Arigo Biolaboratories Corp. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Arigo Biolaboratories Corp. Main Business Overview
11.9.5 Arigo Biolaboratories Corp. Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck CD137 Antibody Product Offered
11.10.3 Merck CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Cell Signaling Technology, Inc.
11.11.1 Cell Signaling Technology, Inc. Company Information
11.11.2 Cell Signaling Technology, Inc. CD137 Antibody Product Offered
11.11.3 Cell Signaling Technology, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Cell Signaling Technology, Inc. Main Business Overview
11.11.5 Cell Signaling Technology, Inc. Latest Developments
11.12 MyBiosource, Inc.
11.12.1 MyBiosource, Inc. Company Information
11.12.2 MyBiosource, Inc. CD137 Antibody Product Offered
11.12.3 MyBiosource, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 MyBiosource, Inc. Main Business Overview
11.12.5 MyBiosource, Inc. Latest Developments
11.13 Boster Biological Technology
11.13.1 Boster Biological Technology Company Information
11.13.2 Boster Biological Technology CD137 Antibody Product Offered
11.13.3 Boster Biological Technology CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Boster Biological Technology Main Business Overview
11.13.5 Boster Biological Technology Latest Developments
11.14 Biocare Medical, LLC
11.14.1 Biocare Medical, LLC Company Information
11.14.2 Biocare Medical, LLC CD137 Antibody Product Offered
11.14.3 Biocare Medical, LLC CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Biocare Medical, LLC Main Business Overview
11.14.5 Biocare Medical, LLC Latest Developments
11.15 Signalway Antibody LLC
11.15.1 Signalway Antibody LLC Company Information
11.15.2 Signalway Antibody LLC CD137 Antibody Product Offered
11.15.3 Signalway Antibody LLC CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Signalway Antibody LLC Main Business Overview
11.15.5 Signalway Antibody LLC Latest Developments
11.16 NSJ Bioreagents
11.16.1 NSJ Bioreagents Company Information
11.16.2 NSJ Bioreagents CD137 Antibody Product Offered
11.16.3 NSJ Bioreagents CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 NSJ Bioreagents Main Business Overview
11.16.5 NSJ Bioreagents Latest Developments
11.17 Leinco Technologies
11.17.1 Leinco Technologies Company Information
11.17.2 Leinco Technologies CD137 Antibody Product Offered
11.17.3 Leinco Technologies CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Leinco Technologies Main Business Overview
11.17.5 Leinco Technologies Latest Developments
11.18 Wuhan Fine Biotech Co., Ltd.
11.18.1 Wuhan Fine Biotech Co., Ltd. Company Information
11.18.2 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Offered
11.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Wuhan Fine Biotech Co., Ltd. Main Business Overview
11.18.5 Wuhan Fine Biotech Co., Ltd. Latest Developments
11.19 Elabscience Biotechnology Inc.
11.19.1 Elabscience Biotechnology Inc. Company Information
11.19.2 Elabscience Biotechnology Inc. CD137 Antibody Product Offered
11.19.3 Elabscience Biotechnology Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Elabscience Biotechnology Inc. Main Business Overview
11.19.5 Elabscience Biotechnology Inc. Latest Developments
11.20 Biotium
11.20.1 Biotium Company Information
11.20.2 Biotium CD137 Antibody Product Offered
11.20.3 Biotium CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Biotium Main Business Overview
11.20.5 Biotium Latest Developments
11.21 Bioss Inc
11.21.1 Bioss Inc Company Information
11.21.2 Bioss Inc CD137 Antibody Product Offered
11.21.3 Bioss Inc CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Bioss Inc Main Business Overview
11.21.5 Bioss Inc Latest Developments
11.22 Miltenyi Biotec
11.22.1 Miltenyi Biotec Company Information
11.22.2 Miltenyi Biotec CD137 Antibody Product Offered
11.22.3 Miltenyi Biotec CD137 Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Miltenyi Biotec Main Business Overview
11.22.5 Miltenyi Biotec Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. CD137 Antibody Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibody
Table 3. Major Players of Polyclonal Antibody
Table 4. CD137 Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CD137 Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CD137 Antibody Market Size Market Share by Type (2017-2022)
Table 7. CD137 Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CD137 Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CD137 Antibody Market Size Market Share by Application (2017-2022)
Table 10. Global CD137 Antibody Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CD137 Antibody Revenue Market Share by Player (2020-2022)
Table 12. CD137 Antibody Key Players Head office and Products Offered
Table 13. CD137 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CD137 Antibody Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CD137 Antibody Market Size Market Share by Regions (2017-2022)
Table 18. Americas CD137 Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CD137 Antibody Market Size Market Share by Country (2017-2022)
Table 20. Americas CD137 Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CD137 Antibody Market Size Market Share by Type (2017-2022)
Table 22. Americas CD137 Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CD137 Antibody Market Size Market Share by Application (2017-2022)
Table 24. APAC CD137 Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CD137 Antibody Market Size Market Share by Region (2017-2022)
Table 26. APAC CD137 Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CD137 Antibody Market Size Market Share by Type (2017-2022)
Table 28. APAC CD137 Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CD137 Antibody Market Size Market Share by Application (2017-2022)
Table 30. Europe CD137 Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CD137 Antibody Market Size Market Share by Country (2017-2022)
Table 32. Europe CD137 Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CD137 Antibody Market Size Market Share by Type (2017-2022)
Table 34. Europe CD137 Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CD137 Antibody Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CD137 Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CD137 Antibody Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CD137 Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CD137 Antibody Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CD137 Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CD137 Antibody Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CD137 Antibody
Table 43. Key Market Challenges & Risks of CD137 Antibody
Table 44. Key Industry Trends of CD137 Antibody
Table 45. Global CD137 Antibody Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CD137 Antibody Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CD137 Antibody Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CD137 Antibody Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CD137 Antibody Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CD137 Antibody Market Size Market Share Forecast by Application (2023-2028)
Table 51. Sino Biological, Inc. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 52. Sino Biological, Inc. CD137 Antibody Product Offered
Table 53. Sino Biological, Inc. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Sino Biological, Inc. Main Business
Table 55. Sino Biological, Inc. Latest Developments
Table 56. Thermo Fisher Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 57. Thermo Fisher CD137 Antibody Product Offered
Table 58. Thermo Fisher Main Business
Table 59. Thermo Fisher CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Thermo Fisher Latest Developments
Table 61. LifeSpan BioSciences, Inc Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 62. LifeSpan BioSciences, Inc CD137 Antibody Product Offered
Table 63. LifeSpan BioSciences, Inc Main Business
Table 64. LifeSpan BioSciences, Inc CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. LifeSpan BioSciences, Inc Latest Developments
Table 66. BioLegend Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 67. BioLegend CD137 Antibody Product Offered
Table 68. BioLegend Main Business
Table 69. BioLegend CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. BioLegend Latest Developments
Table 71. Abcam Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 72. Abcam CD137 Antibody Product Offered
Table 73. Abcam Main Business
Table 74. Abcam CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Abcam Latest Developments
Table 76. Bio-Techne Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 77. Bio-Techne CD137 Antibody Product Offered
Table 78. Bio-Techne Main Business
Table 79. Bio-Techne CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bio-Techne Latest Developments
Table 81. GeneTex Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 82. GeneTex CD137 Antibody Product Offered
Table 83. GeneTex Main Business
Table 84. GeneTex CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. GeneTex Latest Developments
Table 86. Bio-Rad Laboratories, Inc. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 87. Bio-Rad Laboratories, Inc. CD137 Antibody Product Offered
Table 88. Bio-Rad Laboratories, Inc. Main Business
Table 89. Bio-Rad Laboratories, Inc. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Bio-Rad Laboratories, Inc. Latest Developments
Table 91. Arigo Biolaboratories Corp. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 92. Arigo Biolaboratories Corp. CD137 Antibody Product Offered
Table 93. Arigo Biolaboratories Corp. Main Business
Table 94. Arigo Biolaboratories Corp. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Arigo Biolaboratories Corp. Latest Developments
Table 96. Merck Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 97. Merck CD137 Antibody Product Offered
Table 98. Merck Main Business
Table 99. Merck CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Merck Latest Developments
Table 101. Cell Signaling Technology, Inc. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 102. Cell Signaling Technology, Inc. CD137 Antibody Product Offered
Table 103. Cell Signaling Technology, Inc. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Cell Signaling Technology, Inc. Main Business
Table 105. Cell Signaling Technology, Inc. Latest Developments
Table 106. MyBiosource, Inc. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 107. MyBiosource, Inc. CD137 Antibody Product Offered
Table 108. MyBiosource, Inc. Main Business
Table 109. MyBiosource, Inc. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. MyBiosource, Inc. Latest Developments
Table 111. Boster Biological Technology Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 112. Boster Biological Technology CD137 Antibody Product Offered
Table 113. Boster Biological Technology Main Business
Table 114. Boster Biological Technology CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Boster Biological Technology Latest Developments
Table 116. Biocare Medical, LLC Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 117. Biocare Medical, LLC CD137 Antibody Product Offered
Table 118. Biocare Medical, LLC Main Business
Table 119. Biocare Medical, LLC CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Biocare Medical, LLC Latest Developments
Table 121. Signalway Antibody LLC Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 122. Signalway Antibody LLC CD137 Antibody Product Offered
Table 123. Signalway Antibody LLC Main Business
Table 124. Signalway Antibody LLC CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Signalway Antibody LLC Latest Developments
Table 126. NSJ Bioreagents Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 127. NSJ Bioreagents CD137 Antibody Product Offered
Table 128. NSJ Bioreagents Main Business
Table 129. NSJ Bioreagents CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. NSJ Bioreagents Latest Developments
Table 131. Leinco Technologies Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 132. Leinco Technologies CD137 Antibody Product Offered
Table 133. Leinco Technologies Main Business
Table 134. Leinco Technologies CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Leinco Technologies Latest Developments
Table 136. Wuhan Fine Biotech Co., Ltd. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 137. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Offered
Table 138. Wuhan Fine Biotech Co., Ltd. Main Business
Table 139. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Wuhan Fine Biotech Co., Ltd. Latest Developments
Table 141. Elabscience Biotechnology Inc. Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 142. Elabscience Biotechnology Inc. CD137 Antibody Product Offered
Table 143. Elabscience Biotechnology Inc. Main Business
Table 144. Elabscience Biotechnology Inc. CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Elabscience Biotechnology Inc. Latest Developments
Table 146. Biotium Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 147. Biotium CD137 Antibody Product Offered
Table 148. Biotium Main Business
Table 149. Biotium CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Biotium Latest Developments
Table 151. Bioss Inc Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 152. Bioss Inc CD137 Antibody Product Offered
Table 153. Bioss Inc CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Bioss Inc Main Business
Table 155. Bioss Inc Latest Developments
Table 156. Miltenyi Biotec Details, Company Type, CD137 Antibody Area Served and Its Competitors
Table 157. Miltenyi Biotec CD137 Antibody Product Offered
Table 158. Miltenyi Biotec Main Business
Table 159. Miltenyi Biotec CD137 Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Miltenyi Biotec Latest Developments
List of Figures
List of Figures
Figure 1. CD137 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CD137 Antibody Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CD137 Antibody Market Size Market Share by Type in 2021
Figure 7. CD137 Antibody in Flow Cytometry
Figure 8. Global CD137 Antibody Market: Flow Cytometry (2017-2022) & ($ Millions)
Figure 9. CD137 Antibody in ELISA
Figure 10. Global CD137 Antibody Market: ELISA (2017-2022) & ($ Millions)
Figure 11. CD137 Antibody in Immunoprecipitation
Figure 12. Global CD137 Antibody Market: Immunoprecipitation (2017-2022) & ($ Millions)
Figure 13. CD137 Antibody in Other
Figure 14. Global CD137 Antibody Market: Other (2017-2022) & ($ Millions)
Figure 15. Global CD137 Antibody Market Size Market Share by Application in 2021
Figure 16. Global CD137 Antibody Revenue Market Share by Player in 2021
Figure 17. Global CD137 Antibody Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CD137 Antibody Market Size 2017-2022 ($ Millions)
Figure 19. APAC CD137 Antibody Market Size 2017-2022 ($ Millions)
Figure 20. Europe CD137 Antibody Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CD137 Antibody Market Size 2017-2022 ($ Millions)
Figure 22. Americas CD137 Antibody Value Market Share by Country in 2021
Figure 23. Americas CD137 Antibody Consumption Market Share by Type in 2021
Figure 24. Americas CD137 Antibody Market Size Market Share by Application in 2021
Figure 25. United States CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CD137 Antibody Market Size Market Share by Region in 2021
Figure 30. APAC CD137 Antibody Market Size Market Share by Application in 2021
Figure 31. China CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CD137 Antibody Market Size Market Share by Country in 2021
Figure 38. Europe CD137 Antibody Market Size Market Share by Type in 2021
Figure 39. Europe CD137 Antibody Market Size Market Share by Application in 2021
Figure 40. Germany CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CD137 Antibody Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CD137 Antibody Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CD137 Antibody Market Size Market Share by Application in 2021
Figure 48. Egypt CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CD137 Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 54. APAC CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 55. Europe CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 57. United States CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 58. Canada CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 61. China CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 62. Japan CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 63. Korea CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 65. India CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 66. Australia CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 67. Germany CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 68. France CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 69. UK CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 70. Italy CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 71. Russia CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 72. Spain CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 75. Israel CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CD137 Antibody Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CD137 Antibody Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets